Skip to main content
Top
Gepubliceerd in:

09-11-2017 | Brief Report

Baseline predictors of DMT reinitiation among patients with multiple sclerosis following an MI–CBT intervention

Auteurs: Joanie Thelen, Amanda Bruce, Delwyn Catley, Sharon Lynch, Kathy Goggin, Andrea Bradley-Ewing, Morgan Glusman, Abigail Norouzinia, Lauren Strober, Jared Bruce

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 2/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Patients with multiple sclerosis (MS) are often nonadherent to their disease modifying therapy (DMT). While recent studies demonstrate enhanced DMT adherence following intervention grounded in motivational interviewing (MI), little is known about how to address DMT reinitiation among MS patients who have prematurely discontinued DMT against medical advice and do not intend to reinitiate. We examined baseline predictors of DMT reinitiation among patients with MS who discontinued medications against medical advice following a telephone-based MI and Cognitive Behavioral Therapy (MI–CBT) intervention. Following MI–CBT intervention, 66 patients reported whether or not they opted to reinitiate DMT. Rate of disease progression (β = 0.295) and perceived personal control (β = − 0.131) emerged as unique significant predictors of DMT reinitiation following intervention. Clinical characteristics and health-related beliefs may be used to prospectively identify patients most likely to reinitiate DMT following MI–CBT intervention, furthering the goal of preserving brain health and preventing neurologic decline in MS via appropriate DMT utilization. Further study is warranted to delineate potential mediators and moderators of DMT reinitiation outcomes.
Literatuur
go back to reference Affleck, G., Tennen, H., Pfeiffer, C., & Fifield, J. (1987). Appraisals of control and predictability in adapting to a chronic disease. Journal of Personality and Social Psychology, 53, 273–279.CrossRefPubMed Affleck, G., Tennen, H., Pfeiffer, C., & Fifield, J. (1987). Appraisals of control and predictability in adapting to a chronic disease. Journal of Personality and Social Psychology, 53, 273–279.CrossRefPubMed
go back to reference Arnett, P. A. (2003). Neuropsychological presentation and treatment of demyelinating disorders. In U. K. P. Halligan & J. Marshall (Eds.), Handbook of Clinical neuropsychology (pp. 528–543). Oxford: Oxford University Press. Arnett, P. A. (2003). Neuropsychological presentation and treatment of demyelinating disorders. In U. K. P. Halligan & J. Marshall (Eds.), Handbook of Clinical neuropsychology (pp. 528–543). Oxford: Oxford University Press.
go back to reference Berger, B. A., Liang, H., & Hudmon, K. S. (2005). Evaluation of software-based telephone counseling to enhance medication persistency among patients with multiple sclerosis. Journal of the American Pharmacists Association, 45, 466–472.CrossRefPubMed Berger, B. A., Liang, H., & Hudmon, K. S. (2005). Evaluation of software-based telephone counseling to enhance medication persistency among patients with multiple sclerosis. Journal of the American Pharmacists Association, 45, 466–472.CrossRefPubMed
go back to reference Burish, T. G., Carey, M. P., Wallston, K. A., Stein, M. J., Jamison, R. N., & Naramore Lyles, J. (1984). Health locus of control and chronic disease: An external orientation may be advantageous. Journal of Social and Clinical Psychology, 2, 326–332.CrossRef Burish, T. G., Carey, M. P., Wallston, K. A., Stein, M. J., Jamison, R. N., & Naramore Lyles, J. (1984). Health locus of control and chronic disease: An external orientation may be advantageous. Journal of Social and Clinical Psychology, 2, 326–332.CrossRef
go back to reference Charles, C., Gafni, A., & Whelan, T. (1997). Shared decision-making in the medical encounter: What does it mean? (Or it takes at least two to tango). Social Science and Medicine, 44, 681–692.CrossRefPubMed Charles, C., Gafni, A., & Whelan, T. (1997). Shared decision-making in the medical encounter: What does it mean? (Or it takes at least two to tango). Social Science and Medicine, 44, 681–692.CrossRefPubMed
go back to reference Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994). Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale. Clinical Infectious Diseases, 18, S79–S83.CrossRefPubMed Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994). Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale. Clinical Infectious Diseases, 18, S79–S83.CrossRefPubMed
go back to reference Hayes, S. C., Bissett, R. T., Korn, Z., Zettle, R. D., Cooper, L. D., & Grundt, A. M. (1999). The impact of acceptance versus control rationales on pain tolerance. The Psychological Record, 46, 33–47.CrossRef Hayes, S. C., Bissett, R. T., Korn, Z., Zettle, R. D., Cooper, L. D., & Grundt, A. M. (1999). The impact of acceptance versus control rationales on pain tolerance. The Psychological Record, 46, 33–47.CrossRef
go back to reference Hutchinson, M. (2005). Treatment adherence: What is the best that can be achieved? The International Journal of MS Care, 12, 73. Hutchinson, M. (2005). Treatment adherence: What is the best that can be achieved? The International Journal of MS Care, 12, 73.
go back to reference Kraft, G. H., Freal, J. E., & Coryell, J. K. (1986). Disability, disease duration, and rehabilitation service needs in multiple sclerosis: Patient perspectives. Archives of Physical Medicine and Rehabilitation, 67, 164–168.CrossRefPubMed Kraft, G. H., Freal, J. E., & Coryell, J. K. (1986). Disability, disease duration, and rehabilitation service needs in multiple sclerosis: Patient perspectives. Archives of Physical Medicine and Rehabilitation, 67, 164–168.CrossRefPubMed
go back to reference Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33, 1444–1452.CrossRefPubMed Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33, 1444–1452.CrossRefPubMed
go back to reference Miller, W., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed.). New York: The Guilford Press. Miller, W., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed.). New York: The Guilford Press.
go back to reference Mohr, D. C., Goodkin, D. E., Likosky, W., Gatto, N., Baumann, K. A., & Rudick, R. A. (1997). Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Archives of Neurology, 54, 531–533.CrossRefPubMed Mohr, D. C., Goodkin, D. E., Likosky, W., Gatto, N., Baumann, K. A., & Rudick, R. A. (1997). Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Archives of Neurology, 54, 531–533.CrossRefPubMed
go back to reference Nagy, V. T., & Wolfe, G. R. (1983). Chronic illness and health locus of control beliefs. Journal of Social and Clinical Psychology, 1, 58–65.CrossRef Nagy, V. T., & Wolfe, G. R. (1983). Chronic illness and health locus of control beliefs. Journal of Social and Clinical Psychology, 1, 58–65.CrossRef
go back to reference Noyes, K., & Weinstock-Guttman, B. (2013). Impact of diagnosis and early treatment on the course of multiple sclerosis. The American Journal of Managed Care, 19, s321–s331.PubMed Noyes, K., & Weinstock-Guttman, B. (2013). Impact of diagnosis and early treatment on the course of multiple sclerosis. The American Journal of Managed Care, 19, s321–s331.PubMed
go back to reference Ritvo, P. G., Fischer, J. S., Miller, D. M., Andrews, H., Paty, D., & LaRocca, N. G. (1997). Multiple Sclerosis Quality of Life Inventory: A user’s manual. New York, NY: National Multiple Sclerosis Society. Ritvo, P. G., Fischer, J. S., Miller, D. M., Andrews, H., Paty, D., & LaRocca, N. G. (1997). Multiple Sclerosis Quality of Life Inventory: A user’s manual. New York, NY: National Multiple Sclerosis Society.
go back to reference Stewart, A. L., Hays, R. D., & Ware, J. E. (1988). The MOS short-form general health survey. Reliability and validity in a patient population. Medical Care, 26, 724–735.CrossRefPubMed Stewart, A. L., Hays, R. D., & Ware, J. E. (1988). The MOS short-form general health survey. Reliability and validity in a patient population. Medical Care, 26, 724–735.CrossRefPubMed
go back to reference Veit, C. T., & Ware, J. E., Jr. (1983). The structure of psychological distress and well-being in general populations. Journal of Consulting and Clinical Psychology, 51, 730–742.CrossRefPubMed Veit, C. T., & Ware, J. E., Jr. (1983). The structure of psychological distress and well-being in general populations. Journal of Consulting and Clinical Psychology, 51, 730–742.CrossRefPubMed
go back to reference Wallston, K. A., Strudler Wallston, B., Smith, S., & Dobbins, C. J. (1987). Perceived control and health. Current Psychological Research & Reviews, 6, 5–25.CrossRef Wallston, K. A., Strudler Wallston, B., Smith, S., & Dobbins, C. J. (1987). Perceived control and health. Current Psychological Research & Reviews, 6, 5–25.CrossRef
Metagegevens
Titel
Baseline predictors of DMT reinitiation among patients with multiple sclerosis following an MI–CBT intervention
Auteurs
Joanie Thelen
Amanda Bruce
Delwyn Catley
Sharon Lynch
Kathy Goggin
Andrea Bradley-Ewing
Morgan Glusman
Abigail Norouzinia
Lauren Strober
Jared Bruce
Publicatiedatum
09-11-2017
Uitgeverij
Springer US
Gepubliceerd in
Journal of Behavioral Medicine / Uitgave 2/2018
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI
https://doi.org/10.1007/s10865-017-9900-9

Andere artikelen Uitgave 2/2018

Journal of Behavioral Medicine 2/2018 Naar de uitgave